BioSpace News Archive

Apollo Endosurgery, Inc., a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced highlights from Digestive Disease Week 2021 which was held May 21-23.

MindMed (NASDAQ: MNMD, NEO: MMED, DE: MMQ), a leading clinical stage psychedelic medicine company, and Nextage Therapeutics (TASE: NXTG), an Israeli innovative drug development company, announce the execution of a Memorandum of Understanding (the “MOU”) regarding the launch of an exclusive collaborative development program to optimize the delivery of certain psychedelic drug candidates

Activity demonstrated across targeted biologies, including amino acid balance, ammonia handling, muscle function and neurocognition Presentation includes new subject-specific neurocognition and muscle function data

Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders n

ImpriMed, Inc., a leading veterinary precision medicine biotech startup announced the launching of their most advanced precision medicine service for canine hematopoietic cancers - ImpriMed Chemo Response Prediction and ImpriMed Immunophenotyping for Canine Lymphoma.

10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating virtually in the following investor conferences: William Blair 41 st Annual Growth Stock Conference Fireside Chat on Wednesday, June 2 nd at 2:20 p.m. Eastern Time/11:20 p.m. Pacific Time

According to a new report published by Transparency Market Research titled “Immunohematology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”, the global immunohematology market was valued at US$ 1,462.1 Mn in 2016 and is projected to expand at a CAGR of 3.5% from 2017 to 2025 to reach value of US$ 1,991.8 Mn by 2025.

The global market for cervical dysplasia features a highly consolidated competitive landscape, with the top three companies accounting for more than three-fourth of the overall market in 2017, observes a recent report by Transparency Market Research.

Recent approvals to novel drugs for the treatment of Folliculotropic Mycosis Fungoides by international organizations will aid the overall expansion of the market

Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs, announced that on 13 May 2021, two pharmaceutical products of the Company, namely Bimatoprost Timolol eye drop and Epinastine HCl eye drop, passed the on-site inspection for drug registration of the Greater Bay Area Center for Drug Evaluation of NMPA.